Psychiatric conditions (including substance misuse disorders) are serious, potentially life
threatening illnesses that can be successfully treated by psychotropic drugs, even during …

Objective Conflicting data have led to controversy regarding antidepressant use during
pregnancy. The objectives of this study are to i) review the risks of untreated depression and …

Objectives. This 2013 update of the practice guidelines for the biological treatment of
unipolar depressive disorders was developed by an international Task Force of the World …

Objective To assess the safety profile of erenumab, galcanezumab and fremanezumab in
pregnancy and lactation. Methods Safety reports of suspected adverse drug reactions were …

Objective Antidepressant use during gestation has been associated with risk of major
congenital malformations but estimates can lack statistical power or be confounded by …

Objective To write clinical guidelines for the use of psychotropic drugs during pregnancy and
breast‐feeding for daily practice in psychiatry, obstetrics and paediatrics. Method As we …

Background: The association between the use of nonaspirin nonsteroidal anti-inflammatory
drugs (NSAIDs) during pregnancy and the risk of spontaneous abortion remains unclear …

Background Psychiatric disorders are equally common during pregnancy as among non-
pregnant women, and many of these conditions are treated with psychotropic medicines …

Introduction Preterm birth is a major contributor to neonatal morbidity and mortality and its
rate has been increasing over the past two decades. Antidepressant medication use during …

Results of previous studies on the safety of antidepressants during pregnancy have been
conflicting. The primary objective of this study was to investigate whether first-trimester …